Paul Horstmeier, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 21,500 shares at $56.20 ($1.2M) on 2021-08-05, disclosed to the SEC on 2021-08-09.
Open-market sale of $1.2M HCAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.16 | 5,542 | $306K | 25.5% |
| 2 | $55.16 | 5,542 | $306K | 25.5% |
| 3 | $56.20 | 3,153 | $177K | 14.8% |
| 4 | $56.20 | 3,153 | $177K | 14.8% |
| 5 | $56.93 | 2,055 | $117K | 9.8% |
| 6 | $56.93 | 2,055 |
| $117K |
| 9.8% |
| Total | $55.80 avg | 21,500 | $1.2M | 100% |
| Filing → |
| HCAT | SELL | 2022-03-11 | $587K | — | Filing → |
| HCAT | SELL | 2022-02-09 | $626K | — | Filing → |
| HCAT | SELL | 2022-01-06 | $791K | — | Filing → |